NCT07325552 iStent Inject Versus Goniotomy With Kahook Dual Blade in Glauocma Treatment
| NCT ID | NCT07325552 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Bialystok |
| Condition | Open Angle Glaucoma (OAG) |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-01-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-01-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to investigate the efficacy of cataract surgery in combination with Kahook Dual Blade Glide goniotomy (KDB) or iStent Inject W Trabecular Microbypass Stent (Istent) in eyes with Open-angle glaucoma.
Eligibility Criteria
Inclusion Criteria: * Only one eye per participant * Clinically significant cataract * Glaucoma or intraocular hypertension treated with one to four medications and no need for filtering glaucoma surgery at the time of study enrollment. * Open chamber angle with Schaffer grading three to four in at least two quadrants Exclusion Criteria: * Previous glaucoma surgery, including cyclodestructive procedures. * Selective Laser Trabeculoplasty (SLT) within 90 days prior to planned surgery. * Exudative age-related macular degeneration, proliferative diabetic retinopathy, clinically significant corneal dystrophy, other eye disease that affect intraocular eye pressure or visual field. * Unable to participate and make written consent due to another medical condition.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07325552 clinical trial?
This trial is open to participants of all sexes, aged 18 Weeks or older, studying Open Angle Glaucoma (OAG). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07325552 currently recruiting?
Yes, NCT07325552 is actively recruiting participants. Contact the research team at joanna.konopinska@umb.edu.pl for enrollment information.
Where is the NCT07325552 trial being conducted?
This trial is being conducted at Bialystok, Poland, Bialystok, Poland.
Who is sponsoring the NCT07325552 clinical trial?
NCT07325552 is sponsored by Medical University of Bialystok. The trial plans to enroll 100 participants.